North America continues to lead the global immuno-oncology landscape, supported by advanced healthcare infrastructure, strong research capabilities, and significant investments in cancer therapeutics. The region has become a focal point for innovative antibody-based treatments that are transforming oncology care. Growing collaboration between biotechnology firms, pharmaceutical companies, and...